PPARG and breast carcinoma: Analysis of the prognostic value related to TR expression showed that patients with breast cancer with low mRNA expression levels of FABP4 (log-rank P = 0.012), ADIPOQ (log-rank P = 0.01), PPARG (log-rank P = 0.00013), and PPARGC1A (log-rank P = 0.02) had worse OS than those with high mRNA levels.